17
Malaria

Malaria Case Study

Embed Size (px)

DESCRIPTION

Malaria & Case Study

Citation preview

Page 1: Malaria Case Study

Malaria

Page 2: Malaria Case Study

DEFINITION Malaria is an infectious disease, which is

caused by protozoan parasites of genus plasmodium.

Causative Organism : Plasmodium falciparum Plasmodium vivax Plasmodium ovale Plasmodium malariae

Page 3: Malaria Case Study
Page 4: Malaria Case Study

The Symptoms of Malaria

Severe malaria• Seizures• Respiratory

distress• Anemia• Organ failure• Coma• Death

Page 5: Malaria Case Study

DIAGNOSIS Microscopic examination of blood Antigen detection test Patients history & clinical observation

Page 6: Malaria Case Study

TREATMENT  4-Aminoquinolines—

Chloroquine, Amodiaquine  Aryl-amino alcohols—

Quinine, Mefloquine, Halofantrine 8-Aminoquinolines—Primaquine Antifolate—

Sulfadoxine, Proguanil, Pyrimethamine Antibiotics—Tetracycline Qinghaosu—Artemisinin (derived from

leeches) New drugs—

Atovaquona, Pyronaridine, Benflumetol

Page 7: Malaria Case Study

PREVENTION Mosquito nets Keep your surroundings clean Mosquito repellants Vaccines for malaria are underdevelopment

PREVENTION IS BETTER THAN CURE

Page 8: Malaria Case Study

Case Study

Page 9: Malaria Case Study

PATIENTS PERFORMA

Name – Mr. X Age – 26 yrs Gender – Male Date of admission – 06/10/12 Date of discharge – 10/10/12

Page 10: Malaria Case Study

Chief complaintsC/O fever, vomiting, back pain, fatigue,

head ache X 3days.History of present illnessH/O back pain ,headache.Past Medical HistoryN/K/C/O DM, HTN, BA, Personal HistoryNon-alcoholic, Non-smoker.

Page 11: Malaria Case Study

Physical Examination Patient is conscious oriented Temp- 104 F Pulse- 90/min Bp- 130/90 mm/Hg RR- 20beats/minSystemic examinationCVS- S1S2+ CNS- NFNDRS- NVBS P/A- Soft

Page 12: Malaria Case Study

LAB INVESTIGATIONData's Observed Value Normal Value

Hb 12.6 gm/dl(↓) 14-18

RBC 4.4million/cubic mm(↓)

4.2-5.6

ESR(1 Hour) 25mm/hr(↑) 15-20

Platelet 110cubic mm (↓) 140-450

Pot 3.1meq/l (↓) 3.5-5.5

Bili (T) 1.8 mg/dl(↑) 0.2-1.4

Bili (D) 1.5mg/dl (↑) 0.0-0.4

Bili (ID) 0.3mm/dl Total-Direct

Page 13: Malaria Case Study

OTHER TEST’S Dengue test – Negative Polymerase chain reaction – Positive MP QBC – Positive (P.vivax)DiagnosisMalaria

Page 14: Malaria Case Study

DRUG CHARTDrugs Dose R.O.A Frequenc

yDuration

IV Fluids 2 Days

Cap. Doxycyclin

e

100mg P/O BD X 5 Days

Tab. Dolo 650mg P/O TDS X 1 Day

Tab. Larigo 600mg P/O OD X 5 Days

Inj. Emeset 4 mg I.V STAT X 2 Days

Page 15: Malaria Case Study

DRUG INTERACTIONS Doxycycline decrease the effect of

amoxicilline by pharmacodynamic antagonism- Use alternatively

Discharge Advice:Tab. Larigo (600mg) OD for 14 daysTab. Dolo (650mg) STATCap. Doxycycline (100mg) BD for 7 DaysReview after 14 Days

Page 16: Malaria Case Study

PATIENTS COUNSELLING Take adequate rest

Drink plenty of clean water.

MB QBC Test recommended after 14 days

Page 17: Malaria Case Study